Hi,
Good morning, and welcome back to
- A new Alzheimer's drug exposes a 'fundamentally flawed' part of how the US pays for drugs;
- The US will likely miss Biden's July 4 vaccination goal;
- GlaxoSmithKline faces a critical investor day as activist investor pressure increases.
If you're new to this newsletter, sign up here. And let me know what we should be paying attention to going forward: adunn@insider.com. On to the news:
Doctors stand to make thousands on a new Alzheimer's drug even if they don't believe it works. It reveals a 'fundamentally flawed' part of America's healthcare system.
- It's not clear if a newly approved Alzheimer's drug is safe and effective.
- Even as many neurologists doubt Aduhelm's benefits, they stand to make more money if they prescribe it.
- Experts say it's the latest example of the overdue need for reform to the US healthcare system.
Read more on Aduhelm's budget-breaking potential here >>
US will likely miss Biden's July 4 COVID-19 goal of having 70% of adults vaccinated, White House says
- The country will likely miss Biden's goal of having 70% of adults partially vaccinated by July 4.
- The White House made the announcement on Tuesday.
- Press secretary Jen Psaki said the goal will likely be achieved a couple weeks after July 4.
With activist investor Elliott breathing down GSK's neck, here are 5 burning questions the pharma giant needs to answer at a critical investor day
- Leaders of GlaxoSmithKline will present their vision for the pharma giant on Wednesday.
GSK has faced mounting questions over its vaccine business and cancer-research strategy.- We're watching for five pressing questions that GSK may attempt to answer.
Hear more about GSK's big day here >>
More stories we're reading today:
- The FDA approved a controversial, $56,000-a-year Alzheimer's drug despite opposition inside the agency, internal memos show (Insider)
- Chadwick Boseman's tragedy is America's tragedy: In colorectal cancer hot spots, young men are dying at higher rates (STAT News)
- A TikTok trend of swinging your arm around like a windmill to stop soreness after vaccine is nonsense, experts say (Insider)
- From game-changer to back-up: J&J's COVID vaccine struggles in Europe (Reuters)
- Andrew